Featured Topics
Calendar

July 15, 2025

Quiet Period (July 15 - August 06)

August 06, 2025

Q2 2025 Results / Quarterly Statement
Bayer Q2 Media Update
Press Releases
Share Price / Index
June 30, 2025
U.S. Supreme Court asks for views of Solicitor General in Durnell case
June 27, 2025
Not intended for U.S. and UK Media
Eylea™ 8 mg with extended 6-month treatment interval approved in the EU
June 03, 2025
Not intended for U.S. and UK Media
U.S. FDA approves third indication of Bayer blockbuster Nubeqa™ (darolutamide) for patients with advanced prostate cancer

Our Products

Our broad product portfolio includes many world-famous brands that have shaped our Bayer brand. With our products, we are helping to find solutions to some of the greatest challenges of our time. So that health and nutrition can be made available to everyone.